Literature DB >> 31741130

Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways.

Nana Nie1, Cui Bai1, Shanai Song2, Yanyan Zhang3, Benzhen Wang4, Zipu Li5.   

Abstract

Kawasaki disease is an immune-mediated acute, systemic vasculitis and is the leading cause of acquired heart disease in children in the developed world. Bifidobacterium (BIF) is one of the dominant bacteria in the intestines of humans and many mammals and is able to adjust the intestinal flora disorder. The Caco-2 cell monolayers were treated with tumor necrosis factor-α (TNF-α) at 10 ng/ml for 24 h to induce the destruction of intestinal mucosal barrier system. Cells viability was detected through Cell Counting Kit-8 assay. Cell apoptosis was measured by flow cytometry and the expression of apoptosis related proteins was also detected through Western blot. The level of pro-inflammatory cytokines interleukin-6 (IL-6) and IL-8 was detected through ELISA, Western blot and qRT-PCR, respectively. Transepithelial electrical resistance (TEER) assay was conducted to value the barrier function of intestinal mucosa. Cell autophagy and NF-κB and p38MAPK pathways associated proteins were examined through Western blot. In the absence of TNF-α treatment, cell viability and apoptosis showed no significant change. TNF-α decreased cell viability and increased cell apoptosis and BIF treatment mitigated the TNF-α-induced change. Then, we found that BIF treatment effectively suppressed TNF-α-induced overexpression of IL-6 and IL-8. Besides, the results of TEER assay showed that barrier function of intestinal mucosa which was destroyed by TNF-α was effectively recovered by BIF treatment. In addition, TNF-α induced autophagy was also suppressed by BIF. Moreover, TNF-α activated NF-κB and p38MAPK signal pathways were also blocked by BIF, SN50 and SB203580. Our present study reveals that BIF plays a protective role in TNF-α-induced inflammatory response in Caco-2 cells through NF-κB and p38MAPK pathways.

Entities:  

Keywords:  Autophagy; BIF; Intestinal immune system; Intestinal microbiota; Kawasaki disease

Mesh:

Substances:

Year:  2019        PMID: 31741130     DOI: 10.1007/s11010-019-03651-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

Review 1.  Enhancing immunity through autophagy.

Authors:  Christian Münz
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 2.  Dietary Additive Probiotics Modulation of the Intestinal Microbiota.

Authors:  Shenglan Hu; Li Wang; Zongyong Jiang
Journal:  Protein Pept Lett       Date:  2017       Impact factor: 1.890

Review 3.  TEER measurement techniques for in vitro barrier model systems.

Authors:  Balaji Srinivasan; Aditya Reddy Kolli; Mandy Brigitte Esch; Hasan Erbil Abaci; Michael L Shuler; James J Hickman
Journal:  J Lab Autom       Date:  2015-01-13

4.  PPARgamma is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2.

Authors:  Markus Schwab; Veerle Reynders; Sandra Ulrich; Nadine Zahn; Jürgen Stein; Oliver Schröder
Journal:  Apoptosis       Date:  2006-10       Impact factor: 4.677

5.  Lymphocyte-derived interferon-gamma mediates ischemia-reperfusion-induced leukocyte and platelet adhesion in intestinal microcirculation.

Authors:  Mohammad Osman; Janice Russell; D Neil Granger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-31       Impact factor: 4.052

6.  Lactobacilli reduce chemokine IL-8 production in response to TNF-α and Salmonella challenge of Caco-2 cells.

Authors:  Da-Yong Ren; Chang Li; Yan-Qing Qin; Rong-Lan Yin; Shou-Wen Du; Fei Ye; Hong-Feng Liu; Mao-Peng Wang; Yang Sun; Xiao Li; Ming-Yao Tian; Ning-Yi Jin
Journal:  Biomed Res Int       Date:  2013-12-28       Impact factor: 3.411

7.  Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model.

Authors:  Xiang Ling; Peng Linglong; Du Weixia; Wei Hong
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

8.  Bifidobacterium bifidum OLB6378 Simultaneously Enhances Systemic and Mucosal Humoral Immunity in Low Birth Weight Infants: A Non-Randomized Study.

Authors:  Katsunori Tanaka; Takamitsu Tsukahara; Takahide Yanagi; Sayuri Nakahara; Ouki Furukawa; Hidemi Tsutsui; Shigeki Koshida
Journal:  Nutrients       Date:  2017-02-26       Impact factor: 5.717

9.  The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

Authors:  Ji Whan Han
Journal:  Korean Circ J       Date:  2017-03-08       Impact factor: 3.243

10.  Viral infections associated with Kawasaki disease.

Authors:  Luan-Yin Chang; Chun-Yi Lu; Pei-Lan Shao; Ping-Ing Lee; Ming-Tai Lin; Tsui-Yien Fan; Ai-Ling Cheng; Wan-Ling Lee; Jen-Jan Hu; Shu-Jen Yeh; Chien-Chih Chang; Bor-Luen Chiang; Mei-Hwan Wu; Li-Min Huang
Journal:  J Formos Med Assoc       Date:  2014-02-01       Impact factor: 3.282

View more
  8 in total

Review 1.  Implication of Gut Microbiota in Cardiovascular Diseases.

Authors:  Wenyi Zhou; Yiyu Cheng; Ping Zhu; M I Nasser; Xueyan Zhang; Mingyi Zhao
Journal:  Oxid Med Cell Longev       Date:  2020-09-26       Impact factor: 6.543

2.  Expression and role of ABIN1 in sepsis: In vitro and in vivo studies.

Authors:  Haolan Li; Aichen Sun; Taocheng Meng; Yan Zhu
Journal:  Open Med (Wars)       Date:  2020-12-04

Review 3.  Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota.

Authors:  Maohua Chen; Wei Lin; Nan Li; Qian Wang; Shaomi Zhu; Anqi Zeng; Linjiang Song
Journal:  Front Microbiol       Date:  2022-08-04       Impact factor: 6.064

4.  Danggui Niantong granules ameliorate rheumatoid arthritis by regulating intestinal flora and promoting mitochondrial apoptosis.

Authors:  Qi-Jin Lu; Jia-Yu Li; Hong-Xin Lin; Yi-Si Cai; Chang-Shun Liu; Li-Ping Fu; Gang Liu; Li-Xia Yuan
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 5.  Gut microbiota: A new therapeutic target for diabetic cardiomyopathy.

Authors:  Suxin Yuan; Zhengyao Cai; Xingzhao Luan; Haibo Wang; Yi Zhong; Li Deng; Jian Feng
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

Review 6.  Transcriptional programmes underlying cellular identity and microbial responsiveness in the intestinal epithelium.

Authors:  Jennifer K Heppert; James M Davison; Cecelia Kelly; Gilberto Padilla Mercado; Colin R Lickwar; John F Rawls
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-06       Impact factor: 46.802

7.  Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes.

Authors:  Yuanzhen Zhang; Guizhi Xia; Xiaojing Nie; Yugui Zeng; Yi Chen; Yifang Qian; Guangming Chen; Jun Huang; Chengfeng Wang; Chuanyin Zhang; Xiaoli Huang; Yuen Yang; Xiaojian Qiu; Fang Yang; Jie Chen; Jun Hu
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

Review 8.  Environmental and Human Microbiome for Health.

Authors:  Bimala Panthee; Saroj Gyawali; Pratiksha Panthee; Kuaanan Techato
Journal:  Life (Basel)       Date:  2022-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.